Abstract
Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Keywords: Late preterm, infants, long-term, outcome.
Current Pediatric Reviews
Title:Long-Term Outcome of Infants Born Late Preterm
Volume: 10 Issue: 4
Author(s): Despoina Gkentzi and Gabriel Dimitriou
Affiliation:
Keywords: Late preterm, infants, long-term, outcome.
Abstract: Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Export Options
About this article
Cite this article as:
Gkentzi Despoina and Dimitriou Gabriel, Long-Term Outcome of Infants Born Late Preterm, Current Pediatric Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573400510666141114224257
DOI https://dx.doi.org/10.2174/1573400510666141114224257 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alkaloids Pharmacological Activities - Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Preclinical Analyses of the Therapeutic Potential of Allopregnanolone to Promote Neurogenesis In Vitro and In Vivo in Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Kernel-Based Feature Selection Techniques for Transport Proteins Based on Star Graph Topological Indices
Current Topics in Medicinal Chemistry Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase
Current Signal Transduction Therapy Biological Drugs in Guillain-Barré Syndrome: An Update
Current Neuropharmacology Somatic Genome Variations in Health and Disease
Current Genomics The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases
Current Pharmaceutical Design Heart Rate Variability Based Prediction of Personalized Drug Therapeutic Response: The Present Status and the Perspectives
Current Topics in Medicinal Chemistry Juvenile Neuronal Ceroid-Lipofuscinosis (Batten Disease): A Brief Review and Update
Current Molecular Medicine Melatonin in Autism Spectrum Disorders
Current Clinical Pharmacology Transcranial Magnetic Stimulation on Rodent Models
CNS & Neurological Disorders - Drug Targets The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder
Current Drug Targets The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Disorder in Milk Proteins: α-Lactalbumin. Part B. A Multifunctional Whey Protein Acting as an Oligomeric Molten Globular “Oil Container” in the Anti-Tumorigenic Drugs, Liprotides
Current Protein & Peptide Science Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain
Medicinal Chemistry Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism In Search of Novel AMPA Potentiators
Recent Patents on CNS Drug Discovery (Discontinued) Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets